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In recent years increased attention has been focussed on fish vaccines and vaccination 
against diseases in farmed fish. In this study, efficacy and side effects of vaccination 
against atypical furunculosis in Atlantic cod (Gadus morhua L.) were studied in an 
experimental trial by using different adjuvants. The different adjuvanted vaccines 
were administered by intraperitoneal injection (i.p.) to Atlantic cod. The adjuvants 
used were CpG DNA, Aluminium hydroxide (Alhydrogel), and Freunds incomplete 
adjuvant (FIA). Efficacy of the vaccines and side effects were determined 12 weeks 
post vaccination, whereas serum antibodies were measured 15 weeks post 
vaccination. 
Vaccination of Atlantic cod against atypical furunculosis protects the fish and elicits 
specific antibody responses to experimental infection with atypical A. salmonicida. 
The atypical A. salmonicida bacterin alone resulted in very good protection 
(RPS=75%), and addition of adjuvant alone or in combination did not improve the 
protection significantly. This indicates that Atlantic cod can be protected against 
atypical furunculosis through non-adjuvanted vaccines. The injection of FIA alone 
gave non-specific protection, while the adjuvants CpG DNA and Aluminium 
hydroxide did not give any non-specific protection. The group, which received CPG 
DNA alone, had a higher mortality (57%) than the saline control group (53%). High 
specific antibody responses were demonstrated in all groups vaccinated with A. 
salmonicida bacterin. The responses were strongest in the groups, which received A. 
salmonicida in FIA. 
The study also assessed the side-effects 12 weeks vaccination. The vaccines 
containing FIA showed the most sever side-effects among the vaccinated group. 
Aluminium hydroxide showed a less degree of the intraabdominal side effects 
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1.1 General introduction 
During the past three decades, aquaculture has developed to become the fastest 
growing food producing sector in many parts of the world and has become the 
characteristic feature of today’s fishery industry. In aquaculture, according to the 
intensive system of production, fish are kept in high densities and the possibility for 
exposure to disease pathogens1, which can be bacterial, parasitic, or viral, throughout 
production cycle is becoming very high (Munro et al., 1993). Under such conditions, 
the problems of the infectious fish diseases become serious and have considerable 
effects. In fact, bacterial and viral diseases of farmed fish have lead to high moralities 
and reduced economical income for the fish farming industry (Pilcher et al., 1980). 
Furthermore, Inglis et al., (1993) stated that fish diseases, particularly those caused by 
bacterial pathogens are the most important causes of losses among fish farm stocks. 
Many pathogens have caused severe, even catastrophic, losses in aquaculture 
industry. For example, infectious salmon anaemia (ISA) virus nearly put the 
Norwegian salmon aquaculture in a real crisis in recent years. Also, bacterial 
infectious diseases, like vibriosis (Vibrio anguillarum) and furunculosis (Aeromonas 
salmonicida), have caused serious problems for the salmon industry in Scandinavia 
(Egidius, 1987). There are many more examples, but what has been mentioned 
reflects the problem. 
In line with the increased economic importance of aquaculture world wide, vaccines 
against several bacterial fish diseases have been developed during the last 15 years, 
vaccination has become an important method to prevent infectious diseases in 
aquaculture industry. Vaccines against many infectious fish diseases, for example 
vibriosis, furunculosis, and red mouth disease (ERM), have become commercially 
available and are very effective in giving protection.  
 Furunculosis and atypical furunculosis are both serious and economically important 
infectious bacterial diseases in salmonids and non-salmonids farming industries 
(Thronton, 1995; Magnadottir et al., 2002). In the Norwegian salmon farming 
industry, furunculosis has caused large economic losses at the end of 1980’s and as a 
consequence all farmed salmon are today vaccinated against furunculosis. The 
                                                          
1 Micro-organisms which infect the fish body and cause diseases (causative agents of the diseases). 
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available vaccines against furunculosis are administered by intraperitoneal injection 
(i.p.) as a multi-component vaccine containing A. salmonicida antigen and mineral 
oil. A remarkably long-lasting protection is shown by the vaccines (Ellis, 1997) and 
as a result of intensive vaccination, the incidence of the disease among salmonids has 
been dramatically reduced. 
 Atlantic cod (Gadus morhua L.) is an economically and historically (Kurlanski, 
1998) important species in the northern Atlantic and in the Norwegian fishery. During 
the last couple of years, there has been a trend of introducing new non-salmonid fish 
species for farming purposes of intensive culture in several countries, for example in 
Iceland, Canada, Norway and Scotland (Tilseth, 1990). The Norwegian aquaculture 
industry, which is based on salmonids will consist of much more than salmon and 
trout farming in the future, such as Atlantic cod, halibut (Hippoglossus hippoglossus), 
spotted wolfish (Anarhichas minor O.), and other marine fish species 
(www.fiskeopprett.no., (2001)). Furthermore, the interest in the intensive culture of 
Atlantic cod has increased dramatically due to a reduced supply from the wild fishery, 
which leads to a high demand for this species on the market. However, as all other 
farmed fish species, cultured cod has showed cannibalism in the early stages of 
culture (Folkvord, 1992; Rosenlund et al., 1993) and susceptibility to infectious 
diseases  (Espelid et al., 1991; Schrøder et al., 1992; Wiklund and Dalsgaard, 1998). 
Therefore, in the context of an expanding industry, many issues are raised in cod 
health and disease control measures to enhance protection of cod against the 
infectious diseases. 
Atypical furunculosis is caused by atypical Aeromonas salmonicida, and has been 
detected in salmonids and non-salmonids in a wide range of both freshwater and 
marine fish species (Conick et al., 1984; Austin and Austin, 1993; Gudmundsdottir 
1998; Wiklund and Dalsgaard 1998). In Iceland, atypical furunculosis is the main 
disease in farmed salmonids and has caused serious losses before vaccination became 
a common practice (Ellis, 1997). Several outbreaks of atypical furunculosis disease in 
Atlantic cod have also been reported and in other species (reviwed by Wiklund and 
Dalsgaard 1998). Therefore, vaccines designed for cod is under investigation. The cod 
farming industry will possibly face the same disease problems as the salmon farming 
industry experienced twenty years ago and because of this, it is of crucial importance 
to gain as much information about effective vaccines against cod diseases as possible.  
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There are different types of adjuvants that have been used in commercially produced 
fish vaccines (Anderson, 1997). One of the most commonly used adjuvants is mineral 
oil, which creates a slow-release depot of the antigen in the body lumen, resulting in a 
prolonged time for which the immune system remains in contact with the antigen. In 
addition, adjuvants stimulate the non-specific part of the immune system (Ellis, 1988). 
However, in many cases these adjuvanted vaccines tend to elicit different intra 
abdominal lesions at the site of injection (Munn &Trust, 1983; Cossarini, 1985) and 
because of these side-effects researchers are investigating adjuvants that augment 
protective immune responses without or with minimal side-effects, by comparing 
various adjuvants (Midtlyng et al., 1996a; Klinman et al., 1999; Weerantna et al., 
2000).  
The work described in this paper forms part of a project, which aims to investigate 
protection against atypical A.  salmonicida in Atlantic cod. One of the goals in this 
project is to examine the use of other adjuvants than oil in cod vaccines and their 
protective immunity against atypical furunculosis. 
 
1.2 Atlantic cod biology 
1.2.1 Species  
Cod is the common name for nearly 60 species of valuable food fish of the family 
Gadidae (King, 1995), order Gadiformes. Other families in the order are also known 
as cod, such as the deep-sea cod of the family Moridae, but the best-known and most 
commercially important cod is the Atlantic cod, Gadus morhua, of the family Gadidae 
(King, 1995).  
The Atlantic cod has three dorsal fins, two anal fins, an unfrocked tail, and a small 
barbel on its lower jaw (Fig.1). It is generally moderate in size, but can weight as 
much as 90 kg, and can be as long as 150 cm (King, 1995; Macer, 1991). The colour 
of the cod is Greenish-grey to blackish-brown and sometimes red, and it has a 
marbled pattern on its head, back, and sides. 
 4
 
Figure 1.1 Atlantic cod (Gadus morhua L.) 
 
1.2.2 Distribution and Habitat 
The Atlantic Cod are a cold-temperate gadoid, distributed in cool waters in the 
Northern Hemisphere. Although they are bottom dwellers, cod can be found 
anywhere from the surface to 500 or 600m and from inshore waters to the edge of the 
continental shelf. The range of the Atlantic cod spans most of the coastal waters of the 
north Atlantic. Atlantic cod are found in the Northeast Atlantic, from Iceland to the 
Norwegian Sea and south to the Baltic Sea and the Bay of Biscay (Jackobsen, 1998; 
Bergstad et al., 1987). In the North West Atlantic their range extends from Greenland 
and south Baffin Island, south along the continental shelf to the Gulf of Maine. 
(http://www.science.mcmaster.ca/biology/4S03/ATCOD-1.HTM). The normal 
temperature range for cod is between –0,5 to 10oC, and it depends on the time of the 
year, location, and the size of the fish. They can be found in waters up to about 20oC.  
 
1.2.3 Reproduction 
Cod show long distance migrations between spawning, feeding and over wintering 
habitats (http://www.umaine.edu/aquaculture/cod/ecology/spawning.htm). 
Cod are total spawners, which means all eggs are produced and spawned at one time 
during the year. In general, fish of the cod family are planktonic spawners, producing 
buoyant, pelagic eggs that mix with the plankton and float freely (Kjesbu, 1989). The 
spawning of cod in the northwest Atlantic is therefore timed with plankton production 
(http://www.umaine.edu/aquaculture/Cod/Ecology/Spawning.htm). 
The cod gather in large numbers during the winter months to spawn. They migrate to 
a number of spawning grounds and release their eggs in depth of about 200m  (King, 
1995). Every egg has a droplet of oil so that it floats and wildly spread by currents. 
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The larval cod become part of the plankton for about 10 weeks. They sink to the 
bottom when they are about 2 cm long, begin to migrate in the second year, and 
spawn when five to eight years old (Kjesbu, 1989).  
 
1.2.4 Feeding 
Atlantic cod is a voracious predator, feeding on the bottom living fish and 
invertebrates (Macer, 1991). The size of the fish plays an important role in what they 
will eat since they have an enormous food range.  Food preference changes as the cod 
grows. Young cod fry feed mainly on copepods, amphipods, and other small 
planktonic crustaceans. Juveniles feed mainly on shrimp, amphipods, euphaussids, 
and on fish and shellfish larvae. Adult cod feed mainly on Capelin, herring, sand 
lauce, founders, young tourbout, crabs, shrimp, brittle stars, combjellies, small cods 
and a host of other species of fish and shellfish. 
 
1.2.5 Status of the stock 
Atlantic cod has been the most important fish species for centuries and has played an 
important role in the development of countries around the North Atlantic (Kurlanski, 
1998). Furthermore, cod is valued as the source of cod-liver oil. They form the basis 
of a historically profitable fishery in the North Atlantic. Such fishing is still an 
important part of the economy in many countries such as Norway, Iceland, Great 
Britain and Canada. Bottom trawling, Danish seine nets, longlines, handlines, and 
pots are all fishing gears used to harvest cod. Thinning of the fish stocks, however, 
has made the culturing of Atlantic cod more viable (Tilseth, 1993). In the early 1980s, 
the production of Atlantic cod fisheries decreased as the cod stocks in the Northern 
Atlantic were severely depleted.  Today, despite the efforts to rebuild and protect the 
cod population through application of different management measures, Atlantic cod 
stocks are still being over harvested.  
 
1.2.6 The immune system of the Atlantic cod 
Atlantic cod possess the same major immunological organs as other teleost species, 
which comprise of head kidney, thymus and spleen (Press and Evensen, 1999: 
Schrøder, 1998). In general, the fish immune system consists of a specific and non-
specific part. The features of the specific immune system are antigen specificity and 
immunological memory.  This means that most or all antigens can be recognised by 
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the specific immune system. Further more, this enables all fish species, including cod, 
to be vaccinated against particular antigens.  
According previous publication, injection of bacterial antigens leads to an elevated 
level of specific antibody in fish (Bøgwald et al., 1991; Erdal and Reitan, 1992; 
Estvez et al., 1994; Eggset et al., 1997). However, these specific responses are not 
observed in cod against V. salmonicida and protein antigens (Pilström and Petersson, 
1991; Schrøder, et al., 1992; Magnadóttir et al., 2001) whereas only limited responses 
was observed against V. anguillarum (Espelid et al., 1991). The serum concentration 
of cod IgM is found to be high compared to salmon and haddock (Israelsson et al., 
1991) and as in other fish species the immunoglobulins in cod are characterised as a 
tetrameric IgM molecule (Pilström and Petersson, 1991). Thus, cod is capable to 
produce immunoglobulins like other fish species.  
Several studies of the genetic mechanisms, which create antibody diversity, have not 
shown other mechanisms in cod compared to other fish species (Pilström and 
Bengtén, 1996; Pilström and Petersson, 1991; Stenvik, 2001). No special features 
were found in the H-chain variable region (VH) repertoire characterised by cDNA 
cloning and sequence analysis (Stenvik et al., 2000) and cloning and analysis the cod 
IgD showed similarity to the delta domains in Atlantic salmon (Stenvik and 
Jørgensen, 2000).  
Because of the difficulties in producing an elicited antibody response in cod it is 
suggested that may be cod depends on other mechanisms to encounter the pathogens 
than other fish species (Israelsson et al., 1991; Daggfeldt, 1994; Schrøder et al., 
1998). 
 
1.3 Atlantic cod aquaculture 
Aquaculture of Atlantic cod is a new industry in several countries, including Norway, 
Britain, Canada and Iceland, (Walden, 2000). The most significant challenge of 
intensive rearing of cod has been a continuous production of large amounts of cod 
larvae under controlled conditions. In recent years, cod producers have made 
promising progress in this field and in 2002 more than three million cod have been 
produced in Norway (www.intrafish.com/intrafish-analysis). It is obvious that the 
significant advancement in the intensive culture of this species depends on its larval 
production. Furthermore, the commercial value of cod encourages farmers to culture 
this species. Therefore, the future looks good for intensive Atlantic cod aquaculture 
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and cod farming will probably become a viable industry in the near future 
(Steinarsson and Bjørnsson, 1999; Bjørnasson et al., 2001). However, Atlantic cod, 
like other fish species, in the intensive culture system, are susceptible to a number of 
pathogens. 
Today, classical viriosis is the main disease problem in cod aquaculture, but outbreaks 
of both atypical furunculosis and coldwater vibriosis have occurred (Willumsen, 
1990; Schrøder et al., 1992; Wiklund and Dalsgaard, 1998).  
 
1.4 Atypical furunculosis and classical furunculosis 
Furunculosis is a serious infectious bacterial disease for both salmonids and non-
salmonid fish species and is characterised by mass mortality among the infected fish 
population. In 1989, furunculosis was endemic in several parts of Norway and caused 
severe losses in the salmonids farming industry.  
The causative agent of the disease is the gram-negative bacterium, A. salmonicida 
(Munro and Hastings, 1993), which is a well-known pathogen in fish. A. salmonicida 
has been classified into subspecies namely, salmonicida, achromogenes, and 
masoucida, smithia, and pectinolytica (Popoff 1984; Pavan et al.,2000).  
Typical furunculosis is caused by homogeneous strains of A.salmonicida subspecies 
salmonicida. Atypical furunculosis is caused by heterogeneous strains of A. 
salmonicida subspecies achromogenes, masoucida, smithia, and pectinolytica (Smith, 
1963; Austin et al., 1989; Pavan et al., 2000). Recently, atypical A. salmonicida has 
been isolated from wild and cultured cod (Wiklund and Dalsgaard, 1998; Magnadottir 
et al., 2002; Lund et al., 2002b). In addition, atypical furuculosis seems to be more 
conspicuous in farmed fish than in wild fish with some host specific virulent variation  
(Wiklund and Dalsgaard, 1998; Lund et al., 2002b). Symptoms of atypical 
furunculosis disease in cod are mainly characterised by skin ulceration and the 
formation of furuncles in the later stages (Magnadóttir et al., 2002). The disease can 
be either acute or chronic and high mortality rates are associated with both infectious 
forms as in salmonids (Bruno et al., 1996). Other symptoms include raised bumps 
underneath the scales and these furuncles contain large numbers of A. salmonicida 
bacteria, which can spread in the water and has been considered to be a source of 
infection (Enger et al., 1992). In the chronic stage of the disease, the furuncles create 
large bleeding ulcers (Munro et al., 1993). 
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Form of transmission and survival of atypical A.  salmonicida in water is not yet 
known and the source of infections remains uncertain (Gudmundsdottir, 1998).  The 
bacteria are found naturally in marine waters (large numbers) and it seems very 
possible that cod could be infected directly from the marine environment. Diseased 
fish may act as a source of infection (Magnadóttir et al., 2002). 
 
1.5 Fish vaccination 
1.5.1 Introduction 
“ Vaccines are preparation of antigens derived from pathogenic organisms, rendered non-
pathogenic by various means, which will stimulate the immune system in such a way as to 
increase the resistance to disease from subsequent infection by a pathogen”        
                                                                                                                                       Ellis (1988) 
  
The purpose of vaccination is to induce protective immunity in an animal. The 
immunity is specific and should be long lasting. Vaccination is prophylactic and is 
much more effective against infectious diseases compared to other types of 
treatments, for example antibiotic treatment. In aquaculture, the vaccine should be 
effective and applicable against the most economically important diseases. The 
commercially available vaccines used against fish bacterial diseases contain 
inactivated bacterial cells. In addition, the vaccines contain adjuvants, which increase 
the efficacy of the vaccines. The commercially available salmon vaccines in 
Norwegian aquaculture are oil-based adjuvanted vaccines and are most often 
multivalent vaccines, containing up to seven different components. 
 The current advances in technology seem to offer a promising future for anti-
bacterial vaccines in fish species. However, it is more difficult to develop effective 
and cheap anti-viral vaccines and anti-parasitic vaccines.  
 
1.5.2 Route of administration  
Vaccines can be administered by injection, immersion, or by oral administration. 
Simply, vaccines can be administered by adding the vaccines to food. The 
disadvantage of this method is the usage of large amounts of antigen within an 
accurate dose of food for each fish (Gravningen et al., 1993; Bøgwald et al., 1993). In 
addition, the acidic environment of the digestive tract may deactivate the vaccine. In 
spite of the above-mentioned limitations, orally administered vaccine has achieved in 
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some countries, effective oral vaccine against enteric red mouth disease (ERD) is used 
for fish, (fish farmer, 2002). 
The immersion administration is useful for mass vaccination especially for small fish. 
Farmers preferred this method because of it is cost effective (Horne and Ellis, 1988).  
The vaccine is applied externally to fish using different techniques including spray, 
direct immersion and flush exposure (Anderson et al., 1983). The antigen then enters 
the fish body through the skin or the gills. The concentration and the duration of 
exposure are important factors, which affect the conclusive results regarding the 
protection using this method. In addition, in spite of more than 15 years of effort with 
anti-furunculosis immersion vaccination, the result did not give proper protection 
(Midtlyng, 1998a). 
The injection administration gives the best and most long-lasting protection. The 
vaccine can be applied by injecting the fish either intra peritoneal (i.p) or 
intramuscularly (i.m).  Also, injection has the advantage of delivering the right dose 
of vaccine antigen,  (Ellis, 1998; Smith, 1988). Injection is the most used method 
however, it is quite expensive due to the intensive labour forces needed to handle fish 
during the vaccination process. 
 
1.5.3 Types of vaccines 
Vaccines can be developed in different ways so that it can develop protective 
immunity against the pathogen in the vaccinated fish. The vaccine components can be 
prepared as inactivated whole cells, DNA vaccines or recombinant or subunit 
vaccines. 
The whole cell inactivated vaccines have a significant advantage over other types in 
their safety and easy development. Almost all the commercially available vaccines are 
inactivated whole bacterial cells. These vaccines are effective and protect fish against 
diseases (Ellis, 1997; Stevenson, 1997). During the recent years also inactivated virus 
vaccines are developed against infectious pancreatic necrosis (IPN) in Atlantic salmon  
(Dixon, 1997).  
The subunit vaccines consist of parts of a pathogen that stimulate the protective 
immunity. Vaccination of Atlantic salmon with recombinant infectious pancreatic 
necrosis virus (IPNV) subunit vaccine induces production of IPNV specific antibodies 
protection. The subunit technique involves the isolation of the glycoprotein gene, 
which encodes the viral protein responsible for inducing a protective immune 
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response in fish (Winton, 1997). DNA vaccines, produced by recombinant DNA 
technology, represent a new area of vaccine development and have been shown to be 
effective to produce immunity to several viral diseases, as infectious pancreas 
necrosis (IPN) and viral haemorrhagic septicaemia virus (VHSV) (Frost and Ness, 
1997) According to Gudding et al., (1999) DNA vaccinations have advantages over 
conventional vaccines because the specific immune response after using DNA 
vaccination include the antibodies, T-helper cells and cytotoxic cells. However, 
before vaccines are applied commercially in aquaculture, safety for fish and the 
environment have to be addressed. 
 
1.5.4 Vaccination against fish diseases 
Before the introduction of vaccines in aquaculture, bacterial diseases of fish were 
controlled in many countries by the use of a wide range of chemotherapeutics i.e. 
antibiotic therapy (Hastings, 1997). In Norway, 47.000 kg of antibiotics in 1987 for 
disease control in salmon farming industry (Markestad et al., 1997). This resulted in 
development of antibiotic resistance in many fish pathogenic bacterial strains. 
Furthermore, there were increasing concerns on the level of antibiotics in fish flesh 
intended for human consumption. According to Inglis et al., (1993) residues of 
antibacterial treatment in fish have had an indirect impact on human health. This also, 
has had environmental impact on aquatic species. 
The increasing problems associated with the usage of antibiotics to control fish 
diseases encourages researchers to investigate the possibility of developing vaccines 
against the major diseases of farmed fish and to emphasise the idea that prevention of 
disease is more important than therapy. 
The first commercial fish vaccines were licensed in Europe and Scandinavia in mid 
1980’s and were protecting against enteric red mouth disease (ERM) and vibriosis 
(Ellis, 1988). The use of these vaccines has greatly reduced the level of infections in 
salomonids and other farmed species. Furthermore, furunculosis vaccines were 
licensed in Europe in 1986; and were introduced to the Norwegian market in 1989 






According to Ellis (1988) an adjuvant can be defined as a “substance administered 
with antigen which non-specifically enhances the immune response”. According to 
Anderson et al., (1997) adjuvants are additives to an antigen, which enhances the 
immune response in fish, resulting in an effective prolonged protection. Therefore, 
addition of adjuvants to fish vaccines for increasing its effectiveness against 
furunculosis or other fish bacterial diseases is important and has been studied for a 
long time in fish vaccine research (Paterson, 1985; Hastings, 1988; Anderson, 1997). 
There are different kinds of adjuvants, such as mineral oil, freunds complete/ 
incomplete adjuvant (FCA /FIA), glucans, and aluminium salts, which have been used 
in fish vaccines (Anderson et al., 1992 &1997; Robertson et al., 1994). The 
commonly used adjuvants is mineral oil, which create a slow-release depot of the 
antigen in the body lumen, resulting in a prolonged time for which the immune 
system remains in contact with the antigen (Ellis, 1988). The oil adjuvanted injectable 
vaccines against A. salmonicida (multivalent or monovalent) give long-lasting 
protection in salmonids and other marine fish species (Midtlyng et al., 1996 a, b; 
Ingilæ, et al., 2000). However, in many cases these adjuvants tend to elicit different 
intra abdominal lesions at the site of injection (Munn and Trust, 1983; Cossarini, 
1985). In addition, depress in growth and qualities of farmed salmonid species are 
observed (Midtlyng and Lillehaug, 1998b).  
FIA is a mineral oil adjuvants used in fish vaccines. Intraperitoneal injection of FIA 
based vaccines give significant enhancement of the immune response and high level 
of protection in vaccinated fish. However, it causes serious visible intra abdominal 
lesions, including visceral adhesion, non-transparent membranes and reduction of the 
growth rate (Midtlyng et al., 1996a; Midtlyng and Lillehauge, 1998b).  
The use of CpG DNA as an adjuvant is a new area in general and in particular in fish. 
In a recently published papers, it has been shown that CpG adjuvant used in fish 
vaccination is a very promising tool for prophylaxis against many bacterial infectious 
diseases in aquacultured fish and other animals model (Weiner et al., 1997; Jørgensen 
et al., 2001; Krieg, 2000; Krieg, 2002).  
Bacterial DNA contains unmethylated CpG motifs, which are more often present in 
bacterial DNA than vertebrate DNA. According to Jørgensen et al., (2001), 
                                                          
2 Latin word mean “ to help”. 
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unmethylated CpG ODNS leads to production of antiviral cytokine activity in Atlantic 
salmon (Salmon salar L.) leucocytes. In addition, studies of rainbow trout 
(Oncorhynchus mykiss) have reported the production of interferon like cytokines in 
the head kidney (www.nfid.org/conferences/vaccine20/absposter). Also, The CpG is 
found to have the ability to induce an innate immune response in fish later challenged 
with the furunculosis causing bacteria A. salmonicida (Carrington et al., 2002). 
However, few studies have been carried out on CpG ODN in fish, these studies point 
to the immunological effects of CpG-ODN and the possibility of using it as adjuvant 
in fish vaccines. In addition, there is no evidence of negative side-effects or toxicity 
(Weeratna et al., 2000). 
Adjuvants containing aluminium compounds are approved adjuvants used in human 
practice. Aluminium hydroxide has been used in rainbow trout but showed no effect 
(Horne et al., 1984). Another aluminium adjuvant is potassium aluminium sulphate 
used in vibrio vaccine.  
 
1.5.6 Vaccination against atypical and typical furunculosis 
Studies of the bacterium and vaccination against typical or classical furunculosis have 
been carried out in salmonids and non-salmonid fish species for more than a 100 years 
(Bernoth et al., 1997). However, few studies are carried out on Atlantic cod. 
Vaccination of salmon by oil-based vaccines against A. salmonicida protects the fish 
against furunclosis and also accompanied by an elevation of specific antibodies even 
at low temperature (Eggset et al., 1997: Madtlyng, 1997).  
According to Bernoth et al., (1997) the importance of furunculosis disease has been 
related to the importance of salmonids fish species and its impact on this industry. In 
addition, Murno and Hasting (1993) indicate the significant of furunculosis. 
Therefore, numerous investigations have been done in order to control the disease by 
vaccination. Furthermore, studies on pathogenicity of the causative bacteria, bacterins 
protective immunity and comparison of different types of vaccines  (Thronton et al., 
1994; Thronton, 1995). All these efforts of research have been done give useful 
results and information, which leads to the present developments in vaccination 
protection and effectiveness of the commercially available vaccines against typical 
and atypical furunculosis (Peterson et al., 1985; Cardella and Eimers, 1990; Lund et 
al., 2002a; Midtlyng, 2000).   
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2. AIM OF THIS STUDY 
 
2.1 The Research Problem 
The use of injectable vaccines included oil adjuvants in salmonids and non-salmonids 
species leads to undesirable intra-abdominal lesions, known as side-effects. These 
side effects seem to be even more pronounced in Atlantic cod compared to salmonids 
(M. Schrøder, pers.comm.).  
 
2.2 Objective of the study 
The main objectives of this study are: 
1. Compare several adjuvant combinations and their ability to induce protection 
against atypical furunculois in Atlantic cod.  
2.  Investigate the side effects of the adjuvants presented in this study, which are 
CpG DNA, Freunds Incomplete Adjuvants (FIA), and Aluminium Hydroxide 
(Alhydragel). 
3. Evaluate the antibody responses after vaccination of Atlantic cod against atypical 
furunculosis.  
 
2.3 Significance of this study 
The finding of this study will increase the existing knowledge of immunoprophylaxis 
in Atlantic cod against atypical A.salmonicida. Furthermore, the findings are also 
expected to assist vaccine industry and interested companies to make effective anti-
atypical furunculosis vaccines for Atlantic cod.  
 
2.4 Thesis out lines 
The first section of this thesis is a general introduction to the topic emphasising the 
biology, and background of vaccination against fish diseases. The second chapter is 
the aim of the presents study, the research problems, and the main objectives of the 
present study will be are presented. 
The third chapter describes the material and methods used in this study, including 
experimental design and procedure. The data collected will be used to calculate the 
relative percent survival (RPS) using special formula (see material and method), and 
these are presented in the result chapter, i.e. the fourth chapter. In addition, all the 
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statistical analysis results will be presented in this chapter. The fifth chapter discusses 
the results of the entire study with respect to the efficacy of the vaccines and the side-
effects of the different adjuvants. The conclusion is presented in the final chapter, 
which is chapter 6.  
 
2.5 Limitation of the present study 
Based on the fact that vaccine effect should be drawn based on the results of various 
biological parameters and environmental factors, the present study is limited in certain 
issues due to different situations and factors. The present vaccines are used on small 
Atlantic cod under experimental conditions. The time limits further investigation of 
the protection and side-effects after 12 weeks. Other factors that could have been 
evaluated are the effect of the adjuvants on other pathogens (as virus) and the 




















3. MATERIALS AND METHODS 
 
This section provides detailed information about the material and methods used to run 
this experimental study. A vaccination trial including one vaccination and one 
challenge experiment was performed at the aquaculture research station and the fish 
health laboratory (FHL), Kårvika, Tromsø, Norway.  
 
3.1. Experimental design 
Atlantic cod (Gadus morhua L.) were intensively reared and obtained from a local 
hatchery (Troms Marin Yngel). The fish were 1 g when transferred to the aquaculture 
research station. The fish were reared in seawater at 10°C, fed on a commercial pellet 
diet, and kept at the experimental unit of the station (L.A) during the experiment. 
When the fish was approximately 35 g they were placed in 10 tanks with 90 fish in 
each tank (300L) as described in Table 3.1. 
 The fish anaesthetised with metomidate (10mg/L) and vaccinated by intraperitoneal 
injection  (i.p.) of 0,1 ml of different vaccines as described in Table 3.2.  
Prior to challenge the fish were anaesthetised with metomidate (10mg/L) and marked 
with fluorescent tags (Northwest marine technology, inc.) as shown in appendix E. 
Individual weights of 20 fish from each group were taken prior to both vaccination 
and challenge. 
For the challenge experiment, 80 fish were transferred to FHL and distributed into 
two tanks (900L). The fish were intraperitoneally (i.p) infected with atypical A. 
salmonicida and mortality was registered daily for 43 days. The cause of death was 
confirmed by seeding samples from the head kidney of moribund fish on blood agar 
plates for reisolation of bacteria and incubated at 12°C for 24 hours. A. salmonicida 
was confirmed by the use of Mono-As kit (Bio-Nor). Intraabdominal lesions were 
recorded in 20 fish per group. Eight fish from each group was left in one tank (300L), 









Table 3.1 Vaccination experiment design of Atlantic cod: groups, antigen, adjuvant  and number of 
fish in each group. (0.9% NaCl). 
 
Group No. Tank No.  Bacterial Antigen Adjuvants No. of fishes 
1 1  A.salmonicida (atypical) CpG FiA 90 
2 2  A.salmonicida (atypical) CpG 90 
3 3  A.salmonicida (atypical) FiA 90 
4 4  A.salmonicida (atypical) CpG+Alum 90 
5 5  A.salmonicida (atypical) - 90 
6 6  NaCl CpG FiA 90 
7 7  NaCl CpG 90 
8 8  NaCl FiA 90 
9 9  NaCl CpG+Alum 90 
10 10  NaCl - 90 
 
 
3.2. Vaccines  
3.2.1 Bacteria 
Atypical A. salmonicida (aAs 4099), originally isolated from cod in Iceland, was used 
for vaccination and challenge of Atlantic cod. 
The bacteria were transferred from glucerol-culture (- 80° C) and seeded  on blood 
agar supplemented with 2% NaCl  and grown at 12°C for 72 hours. One colony was 
transferred to 10 ml of brain heart infusion broth (BHI, Difco) and incubated on an 
orbital shaker at 12°C for 24- 48 hours with shaking. 
The bacterial cells used in the vaccines were inactivated over night after addition of 
formalin 0.5% (v/v), centrifuged (Sorvall SS- 34 at 4000 rpm for 15 minutes) and 
diluted in 2% NaCl to a final concentration of 4x 109 bacteria/ml (OD600 = 4). 
Inactivation was confirmed by seeding the suspension on blood agar with 2% NaCl 





3.2.2 Preparation of vaccines 
The vaccines consist of different adjuvants and atypical A. salmonicida bacterin as 
explained in Table 3.2. The adjuvants used were CpG ODN 2006 (5 mg/ml) with the 
sequence of 24 bases (5´TCGTCGTTTTGTCGTTTTGTCGTT3´) (OliGold). This 
manufacture was chosen because they offered the cheapest CpG . However, the 
extract was in some extend more crude than CpG offered from other producers (J. 
Jørgensen, pers. Comm.). The other adjuvants are Freunds incomplete adjuvant (FIA, 
Sigma) and Aluminium hydroxide gel (Alhydrogel). The bacteria were atypical A. 
salmonicida (aAs 4099). The bacterial stock described above was diluted in order to 
obtain appropriate cell concentration in the different vaccines and added to adjuvants 
(Table 3.3). In vaccine number 1, 3, 6, and 8 the antigen were added to the oil during 
heavily mixing and the vaccines were then stored at 4o C for 24 hours. In the other 
vaccines the antigen and adjuvants were normally mixed.  
 
3.3. Vaccination 
The fish were anaesthetised with metomidate (10 mg/L) and individually vaccinated 
by i.p. of  0.1 ml of the vaccines using 1 ml syringes. The vaccines are described in 
Table 3.2. The concentrations of the components in the vaccines are shown in Table 
3.3. After vaccination the fish were kept in 10 tanks (300L) with 90 fish in each group 
as shown in Table 3.1. The fish were fed a commercial pellet diet through out the 
experiment. The water temperature was registered daily (appendix F). Twenty fish 
from each group were weighted at the time of vaccination. 
 
3.4 Prechallenge experiment 
In order to determine the bacterial dose, which will be used in the challenge 
experiment for the vaccinated groups, a prechallenge experiment was carried out. The 
prechallenge experiment consists of 3 groups of cod  (30 fish/group) were injected 
intramuscular (i.m.) with atypical A.salmonicida strain aAs 4099. The bacterial doses 
used were 6 x 103, 6 x 104, and 6 x 105 bacteria/fish. The strain was transferred from 
glycerol-culture (-80º C) planted on blood agar with 2%NaCl and incubated at 12ºC 
for 48 hours. Pure colonies were transferred to brain heart infusion broth (10 ml) and 
incubated with shaking over night at 12ºC. The bacterial cells were collected by 
centrifugation at 13000 rpm for 5 minutes and resuspended in 0.9% NaCl. The fish 
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weighted 100 g and the i.m.  injection was done on the lateral side of the fish body 
between the second dorsal fin and the lateral line.  
 
Table 3.2 Different vaccine formulations used to vaccinate Atlantic cod. The bacteria are atypical 
A.salmonicida (aAs 4099) with or without CPG DNA, Freunds incomplete adjuvant (FIA), Aluminium 

















1 5 ml 2 ml 10 ml 3 ml - 20 ml 
2 3 ml 1,2 ml - 7,8 - 12 ml 
3 5 ml - 10 ml 5 ml - 20 ml 
4 1,2x1010 6 mg - - 12 ml 12 ml 
5 5 ml - - 15 ml - 20 ml 
6 - 2 ml 10 ml 8 ml - 20 ml 
7 - 1,2 ml - 10,8 ml - 12 ml 
8 - - 10ml 10ml - 20 ml 
9 - 6 mg - - 12 ml 12 ml 





Table 3.3 The concentration of the different components of the vaccines. The bacteria are atypical 
A.salmonicida  (aAs 4099), in CpG DNA,or FIA in combination. 
 
Components Concentration in vaccines Concentration in fish 
Bacteria 109 bacteria/ml 108 bacteria/fish 
CpG (2006) 500 µg/ml 50 µg/fish 
Al (OH)3 13 mg/ml 1.3 mg/fish 




3.5 Tagging system of the fish  
Approximately one month before the challenge, the fish were anaesthetized with 
metomidate (10mg/L) and individually tagged with fluorescent tags (Northwest 
marine technology, inc.) by subcutaneous injection near the operculum. The tagging 
system is shown in appendix E.   
 
3.6 Challenge experiment of the Atlantic cod 
Twelve weeks post vaccination, the challenge was performed with the same atypical 
A. salmonicida strain as used in the vaccination. Eighty fish from each group were 
transported to the fish health laboratory (FHL) anaesthetised with metomidate 
(10mg/L) and i.p. injected with 0.1 ml of atypical A. salmonicida. The fish were not 
intramuscularly (i.m.) infected because the prechallenge resulted in very heavy 
mortality in all groups. Due to this result the intraperitoneal (i.p.) infection was 
chosen. The challenge dose used was 5 x 105 bacteria / fish. This dose was determined 
dependent on a previous prechallenge experiment. The fish were then redistributed in 
two tanks (900L), approximately 40 fish from each group in each tank. Mortality in 
each group was recorded daily. Cumulative mortality was registered and relative 
percent survival (RPS) was recorded at the end of the experiment (day 43 after 
challenge), according to the formula: 
 
RPS=(1-%mortality in vaccinated group/mortality in control group) X 100% 
 
 
3.7 Evaluation of the intraabdominal lesion 
Dead fish, 20 from each group, were examined for side-effects. The dead fish were 
shipped on ice to the laboratory for autopsy the same or the following day. Each fish 
was investigated by a ventral incision of the abdominal cavity and description of the 
visible intraabdominal lesion and adhesions was recorded. According to the visual 
appearance of the abdominal cavity and the severity of the lesions, each fish was 
given a score from zero to three. The score 0= no visible lesions; the score 1= 
injection site adhesions; and the score 2= adhesions between the internal organs by 
non-transparent membrane and liver attached to the internal organ and the abdominal 
wall.  
 20
Some non-infected fish were inspected for side-effects in order to confirm that side-
effects observed in the diseased fish were caused by the vaccine and not by the 
infection  
 
3.8 Blood sampling 
Eight fish from each group were used to collect blood samples for evaluation of the 
post vaccination antibody level fifteen weeks post vaccination. The fish was 
anaesthetised (metomidate10mg/L) and blood was sampled from the caudal vein 
using vacuum tubes and injectable syringes. The blood samples were stored on ice 
over night and centrifuged at 1000 rpm for 10 minutes in order to separate the serum 
from the blood. The sera were stored at – 20°C until use.  
 
3.9 ELISA with atypical A. salmonicida (aA.s.) in Atlantic cod 
The antibody responses in cod to atypical A. salmoncida were measured by Enzyme-
linked Immunosorbent Assay (ELISA) in pooled and individual sera. This test is done 
as described by (Magnadottir et al., 1998c) with some modification. 
Solutions used during the ELISA. 
Phosphate buffered saline (PBS) 
10X: 
220.6 g Na2 HPO4*12H2O 
28.74 g Na H2 PO4*2H2O 
350.4 g NaCl 
4 L of distilled water.  
pH 7.3 
Carbonate buffer 
1.59 g NaCO3 
2.93 g NaHCO3 
1 L distilled water (H2O).   
pH 9.6  
2% saline (2% NaCl) 
20 g NaCl. 
1 litter distilled water (H2O)  
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Washing buffer: 1 x PBS with 0.05% Tween 201 
For making 3 Litres: 
300 ml 10 x PBS  
2700 ml H20 
1.5 ml Tween 20 (Sigma). 
pH 7.4 
5% Dry skimmed milk in PBS 
10 ml 10 x PBS  
90 ml distilled H2O.  
5 g of dry skim milk.  
pH adjusted to 7.4 
0.5% Dry skim milk in PBS 
10 ml 10 x PBS  
90 ml distilled H2O.  
0.5 g dry skim milk. 
pH adjusted the to 7.4 
 Poly-L-Lysin (5µg/ml) 
A stock solution of Poly-L-Lysin in water (5mg/ml, Sigma) was diluted 1:1000 in 
carbonate buffer. 
 Substrate Buffer 
97 ml Diethanolamine  
900 ml distilled H2O 
100 MgCl2 x 6H2O (1mg/ml) 
pH  9.6  
The volume was adjusted to 1 litre. 
  
ELISA was performed in 96-wells polystyrene plates (Nunc). The plates were coated 
with poly-L-Lysin (5µg/ml) in carbonate buffer (100 µl per well) and incubated 
overnight at 4° C. Then the plates were washed with washing buffer and kept at 4° C. 
Atypical A. salmonicida, isolated from the head kidney from the dead fish, were 
cultured on blood agar at 12°C for 24 hours, recultured on blood agar plates 
                                                          
1 Tween 20 chemically is Polyoxethylene-sorbitan monolaurate 
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(supplemented with 2% NaCl), and incubated at 12°C for 3 days. One bacteria colony 
was transferred from the blood agar plate to 5 ml of BHI broth media (18.5 g Heart  
Brain Infusion in 500ml distilled water and autoclaved) and incubated at 12°C for 24 
hours. 1 ml of this cultured bacterium was added to 200 ml BHI broth media, and 
incubated at 12°C for 24 hours.  
The cultured bacteria was fixed by adding 200 µl of formalin to 40 ml bacteria (final 
concentration of 0.5% v/v) and then incubated over night at 4° C.  
The fixed bacteria were centrifuged at 3500 rpm for 15 minutes, at 20° C. The 
sediment was then diluted in 2% NaCl (1:20). Optical density was measured using 
photometry. OD600 was 0.410, which means (4x 108 bacteria/ml). This bacterial 
solution was used to coat the wells of the microtitre plates with 100 µl bacteria per 
well. The plates were centrifuged at 1000 rpm for 10 minutes at 4° C and incubated 
for 30 minutes at room temperature (20°C) in order to coat the bacteria to the wells of 
the microtitre plates the plates. The plates were washed 3 times with the washing 
buffer. The plates were blocked with 125 µl 5% skimmed milk in PBS per well and 
incubated at 4°C over night. The plates were washed 3 times with the washing buffer 
and stored at – 20°C until used. 
The bacteria coated to the microtitre plates were used to measure the antibody level in 
pooled and individual cod serum. The samples of cod serum were pooled and diluted  
1: 100 by adding 5-10 µl pooled serum to 500 –1000 µl of 0.5% Dry skimmed milk. 
Then the sera were two fold diluted from 1: 100 to 1:6400 in two parallel wells and 
incubated at 4°C over night. At this stage, specific cod immunoglobulins will bind to 
the bacteria coated to the microtitre plates. 
The plates were then washed 3 times with the washing buffer and a rabbit anti-cod 
serum (M. B. Schrøder) were diluted 1:800 d in 0.5% (w/v) skimmed milk in PBS, 
was added to the microtiter plates (100 µl per well). The plates were incubated for 2 
hours at room temperature (20°C). 
The plates were washed 3 times with the washing buffer and goat anti-rabbit 
immunoglobulins conjugated with alkaline phosphate  (sigma) diluted 1:30000 in 
0.5% w/v skimmed milk, was added (100µl per well). The plates were incubated at 
room temperature (20°C) for one and a half hour. 
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Finally, after washing 3 times with the washing buffer, 100µl per well of p-nitrofenyl 
phosphate substrate (Sigma) in substrate buffer (1mg/ml) was added to all the wells. 
The plates were incubated in dark for 30- 45 minutes at room temperature (200C) and 
the optical density was read at 405 nm using  “Thermo max microplate reader” 
Version 4.0 Software, (SOFTmax PRO User's Manual Chapter 4). 
 
3.10 Statistical Method of Analysis 
Computerised statistical techniques were used to analyse the results from the primary 
data. A Yates corrected Chi-square test (χ2 ) was used to determine statistical 
differences in mortality between vaccinated groups and unvaccinated group using Ms-
Excel programme. 
Analysis of variance (ANOVA) was used to analyse the ELISA results and also to 
determine the statistical differences in weights between vaccinated groups (Berk and 



















4.1 Prechallenge  
The intramuscular (i.m.) prechallenge of Atlantic cod with atypical A.salmonicida 
resulted in high mortality and all the fish die within 10 days (Fig. 4.1). Because of this 
result the challenge experiment was decided to be with intraperitoneal injection (i.p.) 
and the doses used were based on experience from a previous prechallenge, where 
1.5x105 bacteria per fish gave 35% mortality. We therefore decided to use 5x105 




Figure 4.1Intramuscular (i.m.) infection of   Atlantic cod with atypical A. salmonicida strain aAs 4099 





















6x10(5) bacteria/fish 6x10(4) bacteria/fish 6x10(3) bacteria/fish
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4.2 Vaccination and challenge 
Ten groups of Atlantic cod were vaccinated with different vaccine formulations using 
atypical A.salmonicida bacterin and FIA, CpG, and Aluminium hydroxide adjuvants. 
Approximately eighty fish in each group, equally distributed in two tanks, were 
challenged 12 weeks post vaccination. Fourty-three days post challenge there were no 
significant differences in mortality between each group in the parallel tanks and the 
results from the two tanks are thus presented together. 
 The same atypical A. salmonicida strain (aAs 4099) was used both in the vaccines in 
the prechallenge and in the challenge experiment. All the vaccinated groups were 
infected with a dose of 5x105 bacteria/fish (0.1ml). 
The results from the challenge experiment with atypical A. salmonicida are presented 
as cumulative mortality in Fig 4.2. 
 
 
Figure 4.2 Atlantic cod vaccinated (i.p.) with atypical A.salmonicida (aAs 4099) bacterin alone or in 
combination either with CpG DNA, Freunds incomplete adjuvants (FIA), CpG and Aluminium 
Hydroxide (Alum) or CpG and FIA. Control groups received the respective adjuvants alone. The fish 
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The fish in groups 7 (CpG), group 9 (CpG+Alum), and control group started to die at 
day 5 post challenge. During the next 10 days the mortality in these groups increased 
rapidly and reached 40-50%. The mortality in the other groups did not exceed 20% 
during the experiment. In group 3 (aAs+FIA) the fish started to die at day 9 after 
challenge and the mortality remain low (8%) throughout the infection. At the end of 
the experiment the mortality was declined in all groups. The mortality reached 53% in 
the saline control group, while the mortality in the group 7, (CpG alone), was 57 %.  
The vaccine with bacterin alone resulted in low mortality (13%) and the bacterin with 
FIA resulted in even lower but not significantly, mortality.  
The vaccine CpG+ Alum without antigen resulted in 46% mortality, whereas when 
the antigen was included, the mortality was only 19%. 
 The efficacy of the vaccines is calculated as relative percent survival (RPS) on day 
43 post challenge and the results are presented in Table 4.1 and appendix A.  
 
Table 4.1 Dead, and Survival Atlantic cod and vaccines efficacy (RPS), in the different groups (43 
days post challenge). 
Group 
No 
Vaccine type Challenge strain aAs 4099 
Dead      Survived    Mortality (%)            RPS (%) 
1 aAs+CpG+FIA 8                  73                   10                           81 
2 aAs+CpG 12                71                    14                          73 
3 aAs+FIA 7                  77                      8                          84 
4 aAs+CpG+Alum 16                67                     19                        63 
5 aAs+saline 11                 71                    13                        75 
6 CpG+FIA 12                 71                    14                         73 
7 CpG 47                 36                    57                         -7* 
8 FIA 13                 72                    15                         71 
9 CpG+Alum 37                 43                   46                          12 
10 Saline 39                  35                  53                            0 





Lower mortality was observed in the groups vaccinated with oil-based vaccines 
compared to the control group, even when the fish did not receive antigen. This give a 
RPS of 81%, 84%, 73%, and 71% in group 1 (aAs+CpG+FIA), group 3 (aAs+FIA), 
group 6 (CpG+FIA), and group 8 (FIA) compared to the control group. In addition, 
the mortality in group 5 (aAs in saline) was 13% and the RPS 75%. This indicates that 
bacterin alone can give similar protection as the FIA-emulsified vaccines in Atlantic 
cod, at least during a limited period of time. Further more, the RPS in group 2 (aAs 
+CpG) 73%, which is similar to the mortality in group 5 (aAs+saline). Since the 
protection after vaccination with antigen alone gave such a low mortality, it is not 
possible to make any conclusions about the effect of CpG on the protection in cod. 
Also, CpG alone gave the highest mortality (57 %), which gives a negative RPS 
value. Furthermore, a low protection level was obtained when antigen was combined 
with Alum (RPS= 63%).  
Among the vaccinated groups, the differences were tested by mean of χ2-test analysis. 
The mortality in the vaccinated groups were compared with the control group, with 
each other, or with their counterparts (group received the same adjuvants without 
antigen) and the results are shown in appendix C. The results show that vaccines 
containing antigen gave a higher protection than the control group (p< 0.001). The 
bacterin alone gave significant protection compared to the control group. In the 
groups which received CpG alone or CpG+ Alum the protection level is not 
significant different from the control group.  
Comparisons of the groups which received aAs bacterin with adjuvants and their 
contourparts, showed no significant differences between groups received aAs+FIA or 
aAs+CpG+FIA, whereas there is significant difference between groups received aAs+ 
CpG or aAs+CpG+Alum and their counterparts. This confirms that FIA alone give a 
high non-specific protection in cod (appendix C-2).  
No significant differences in protection between groups received antigen with each 
other (p> 0.05), except (aAs+FIA) and (aAs+CpG+Alum) show small difference (p< 






4.3 Antibody responses to atypical A. salmonicida 
Sera from all the vaccinated groups were collected 15 weeks post vaccination. The 
antibody responses were measured in pooled serum from all the vaccinated groups 
and individual sera from group 1 (aAs+CpG+FIA), group 3 (aAs+FIA), group 6 
(CpG+FIA), and group 8 (FIA). The results showed an increased antibody activity to 
whole cells of atypical A. salmonicida aAs 4099 in pooled sera (Fig.4.3 and appendix 
B). Cod immunised with atypical A. salmonicida bacterin in saline alone or in 
combination with FIA showed high antibody responses, while the other vaccines gave 
low levels of antibody responses. There is significant difference in the antibody 
responses between the vaccinated groups and unvaccinated groups (One way 
ANOVA, p-value 0.00002).  
Results from the individual sera antibody responses are presented in figures 4.5 and 
4.6. The fish were either immunised with aAs+CpG+FIA (group 1) or aAs+FIA 
(group (3) or CpG+FIA (group 6) or FIA alone (group 8). The antibody responses are 





Figure 4.3 Antibody activity in sera from Atlantic cod vaccinated with different vaccines against 
atypical A. salmonicida. The sera were pooled (n=8) and tested against A. salmonicida whole cell in 




































Figure 4.4 Antibody activities in individual sera from Atlantic cod measured against whole cells of 
atypical A. salmonicida (aAs 4099) in ELISA (n=8). The fish were either immunised with 





Figure 4.5 Antibody activities in individual sera from Atlantic cod measured against atypical      
A. salmonicida (aAs 4099) in ELISA (n=8). The fish were either immunised with aAs+ FIA (group 3) 
or FIA alone (group 8). Each line represents one individual. 










































































4.4 Vaccine side-effects 
 Twenty fish from each group were inspected in order to evaluate the side-effect of 
the different vaccines. The lesions were given a score from 0 to 2 (Table 4.2). The 
observed side-effects in the this study is shown in figure 4.7.  
The side-effects were visible in groups of fish vaccinated with FIA and in groups 
vaccinated with Aluminium hydroxide. 
The FIA led to sever intraperitoneal adhesions. The internal organs were firmly 
attached to the abdominal wall and surrounded by non-transparent membranes (Fig. 
4.7 d & e). The non-transparent membranes contained the vaccine droplets. Visible 
adhesions between the liver and the abdominal wall were observed in all the 
investigated fish from these vaccines (group 1, 3, 6 and 8). These side-effects were 
evaluated as score 2. Also, it was found that side-effects were presented in the same 
degree in all the investigated fish treated with FIA.  
The fish which received vaccines containing Aluminium hydroxide showed 
inflammation and adhesions between the abdominal wall and the internal organ close 
to the site of injection. No adhesions were observed elsewhere in the body cavity 
(Fig.7.4c). These side-effects were evaluated as score 1. 
No side-effects were observed in unvaccinated fish, or in fish which received bacterin 
or CpG alone or in combination. This finding was evaluated as score 0. 
There were no significant differences between the non-infected and infected fish. 


















Table 4.2 Score and intra-abdominal lesions in different vaccinated groups of Atlantic cod (Gadus 
morhua L.) 12 - 15 weeks post vaccination.   
 
























2 Liver severely attached to abdominal 
wall and connected with internal 
organs by non-transparent membrane 

























c. Score 1: the liver, the abdominal wall and the internal organs adhesion at the injection site 
 
 
   d.  Score 2: Liver attached to the abdominal                            e.  Score 2: Non transparent         
                                                                                                          membranes between the internal               
                                                                                                          organs. The organs are firmly          
                                                                                                          attached to each other.                                                                                                    
     
Figure 4.6 Side-effects lesion and scores in Atlantic cod vaccinated against atypical 
furunculosis using FIA, CpG DNA and Aluminium hydroxide. a.Unvaccinated fish 
normal internal organs. b . Side-effect of CpG adjuvaned vaccines. c. Side-effect of 
Alum adjuvanted vaccines. d & e: Side-effects of FIA adjuvanted vaccines. 
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The fish were weighted at the time of vaccination and 12 weeks post vaccination 
(figure 4.8, and appendix D). Before the vaccination, there was no significant 
difference in the weights between the fish groups (one way ANOVA, p=0.2515) 
wheras12 weeks post vaccination it was found a significant differences between the 
groups weights in particularly the group vaccinated with aAs+CpG+Alum vaccine (p-







Figure 4.7 Mean weights of Atlantic cod before and after vaccination with the different vaccines 






































5.1 Protection post vaccination 
In the presented work all vaccines containing antigen protected cod highly against 
atypical furunculosis compared to the saline group and no significant differences were 
observed between the groups, which received antigen in different adjuvants. This 
means that addition of adjuvants did not improve the protection significantly, even if 
Freunds incomplete adjuvant (FIA) was used. In contrast to this finding, furunculosis 
vaccines became protective in salmon when mineral oil adjuuvants were added 
(Lillehaug et al., 1992; Midtlyng et al., 1996a; Midtlyng et al.1996b; Gudding et al., 
1999; Midtlyng, 2000). Also, injection of formalin inactiviated A. salmonicida 
without adjuvant in brown trout (Salmo trutta) induces a low protection (Krantz et al., 
1964). Furthermore, vaccination of spotted wolffish and halibut with oil adjuvanted 
vaccines against atypical furunculosis gives good protection.  
Fish injected with FIA alone obtained a high non-specific protection (RPS=71). This 
result is in line with previous findings when vaccinating cod against classical vibriosis 
(Schrøder pers. comm.). Generally, oil-based vaccines are well known to afford long-
term protection against different antigens (Bowden et al., 2003). Their mode of action 
is thought to be in large part due to stimulation of non-specific defence mechanisms 
by low spot release, which can occur in the absence of the vaccine antigen (Oliver et 
al., 1985b; Adams et al., 1988) but exactly how this relates to protection is not yet 
known. Also other adjuvants enhance the protection after vaccination.  
The protection obtained in cod, which received antigen in CpG with Aluminium 
hydroxide and CpG and Aluminium hydroxide was relatively low compared to other 
groups received adjuvanted A. salmonicida bacterin. The mortality in the groups 
receiving CpG alone or in combination with Aluminium Hydroxide was similar to the 
saline control group. This may be due to the combination with CpG adjuvant.  
In consistency with previous reports in salmonids, vaccination with aluminium 
hydroxide adjuvanted bacterins resulted in poor protection of Atlantic cod against 
atypical furunculosis. 
This revealed the role of the antigen in the induction of the protective immunity and 
that the adjuvant alone is not enough for effective protection.  
The CpG in this study gives protection when used in combination with antigen (aAs).  
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However, because of the high protection when vaccinating cod with bacterin alone no 
conclusion can be drawn about the effect of using CpG as an adjuvant in cod. The 
high mortality obtained from the CpG alone may be is a result of its crudeness. 
CpG is known as an adjuvant, which stimulates immune responses in fish through its 
enhancement of antibodies, stimulation of macrophages and production of cytokines, 
such as gamma interferon (IFN-γ) and IL-Iβ, (Jørgensen et al., 2001; Jørgensen et al., 
2002). In murine models, studies of CpG have been reported to activate B cells, 
macrophage, natural killer cells and even more cell types (Mutwiri et al., 2003; 
Harandi et al., 2003). However, details of the mechanisms that mediate protection are 
not fully understood, this is due to the variety of cells activated as well as the spacing 
between CpG motifs, which may influence the type of immune stimulation (Mutwiri 
et al., 2003). Furthermore, the sequence and the number of CpG motifs affect the 
stimulatory activity in Atlantic salmon (Jørgensen et al., 2003). This fact may 
contribute to the poor protection of CpG in cod and different CpG motifs should be 
tested in cod as in salmon. 
The susceptibility of cod to atypical A. salmonicida appears to be high as infected cod 
start to die without showing any of the disease symptoms when infected i.m. or i.p. 
with A. salmonicida (Cornick et al., 1984; Magnadottir et al., 2002). In this study 
vaccination and infection was both done i.p. due to the high mortality with i.m. 
infection. However, after more than one month the diseased fish showed the skin 
ulceration and furuncle in different parts of the body. Since atypical A. salmonicida 
strains are genetically diverse according to Lund et al., 2002b, further test to the 
potency of A. salmonicida bacterin using different strains for challenge is 
recommended.   
 
5.2 Antibody response post vaccination 
In this study, antibody responses to atypical A. salmonicida aAs-99 whole cells, both 
in pooled and individual sera were measured. Surprisingly, specific antibodies 
responses were demonstrated in all groups vaccinated with atypical A. salmonicida. 
The responses were strongest in groups receiving bacterin in FIA, whereas, the level 
of specific antibodies were weaker in fish vaccinated with A. salmonicida in saline. 
The bacterin in CpG alone or in combination with Aluminium hydroxide was least 
effective for augmenting antibody responses.This finiding contradict with previous 
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reports, which showed that the CpG  as an adjuvant, stronger immune response 
against a model antigen in mice was obtained compared to FIA adjuvant (Weeratna et 
al., 2000; Harandi et al., 2003 ). 
The antibody responses in individual sera varied in the level but followed the same 
pattern of responses as the pooled sera. These results indicate that cod can produce a 
significant level of specific antibody response after vaccination against atypical 
furunculosis. Previous work in cod has shown that cod do not produce specific 
antibodies after immunisation with V. salmonicida or protein antigens (Schrøder et 
al., 1992; Pilström and Petersson, 1991) Immunisation with V. anguillarum, however, 
have resulted in weak responses (Espelid et al., 1991). 
Except from this information studies of the immune system of cod has not shown any 
specific features and this indicate that there are no clear differences between the cod 
immune system and the immune system in other fish species (Magnadóttir et al., 
2001: Stenvik 2001). Also, the antibodies obtained in this study confirm that the cod 
immune system does not deviate from other species and that the lack of responses 
might be related to the nature of the antigen.  
Moreover, the results in this study showed that the specific immune responses against 
atypical A. salmonicida were correlated with the protection. The antibody levels and 
the magnitude of protection were consistency positively associated, as the highest 
responses were observed in the groups, which were best protected in the challenge.  
Most studies on the relation between immune response and protection have been 
performed with injectable vaccines. In previous studies with A. salmonicid, protection 
in salmonids was found related to the serum antibody titre (Bricknell et al., 1997; 
Midtlyng et al., 1996a; McCarthy et al., 1998). The production of antibodies, 
resulting from the proliferation of primary effector’s cells and their differentiation 
into both antibody secreting cells and specific memory cells, is often a complex 
process requiring cell cooperation. This is important, since the magnitude of these 
responses will reflect the ability of different vaccines to evoke memory responses to 
atypical A. salmonicida. It is necessary to produce a strong memory response for a 
sustained duration, otherwise antibody titres and cell-mediated response will decline. 
Thus, to be able to develop new, cheap and effective vaccines against atypical 
furunculosis for the growing Atlantic cod aquaculture industry more research should 
focus on the immune system especially the cellular immune system.  
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Further studies have been done on the sera obtained in this study using western 
blotting techniques. The results indicate that the specific antibodies mainly directed 
against the bacterial lipopolysaccharide (LPS) and to less extend to the A-layer (V. 
Lund pers. communication). These findings are not inconsistence with previous 
results in salmon, spotted wolffish and Halibut where immunisation with atypical A. 
salmonicida, resulted in a strong immune response against the A-layer (Lund et al., 
1991; Ingilæ et al., 2000; Lund et al., 2002a). Because little is known about the 
protective antigens in cod against A. salmonicida, further immunological investigation 
of the protective antigens and their impact on protective immunity is important for 
Atlantic cod vaccine development.  
 
5.3 Side-effects3 
In this study, the results of the side-effects of the different vaccine formulations 
showed variations depending on the adjuvant used. The freunds incomplete adjuvants 
(FIA) led to severe peritoneal adhesions and displayed the highest score of side-
effects as the internal organs were firmly attached to the abdominal wall and 
surrounded by non-transparent membranes. Aluminium hydroxide (Alhydrogel) led to 
inflammation and adherence at the site of injection, but no adhesions were observed 
elsewhere in the body cavity. Also, the results showed no side-effects in unvaccinated 
fish or in fish received bacterin or CpG alone or in combination. These results are in 
consistence with previous reports and are well known for freunds adjuvants, which 
leads to visible side-effects in vaccinated fish (Midtlyng et al., 1996a; Midtlyng, 
1997b; Poppe and Breck, 1997).  
The score used in this study is described in relation to extend of adhesions of the inner 
organs and the highest score indicated by (2) followed by less degree score (1) and 
score (0) indicate no side-effects. This score is not in accordance with the Speilberg 
score used in prevoius studies of salmon (Midtlyng et al. 1996a) because side-effects 
in cod appear with the same degree of severity in all investigated fish. These findings 
confirm that the intra-abdominal adhesions of the internal organ and the abdominal 
wall may affect the commercial quality of farmed cod and in particular the further 
used of the cod liver. 
                                                          
3 Side-effects is a term used for various adverse or undesirable effects arises from medical treatments    
  including vaccination (Midtlyng, 1998). 
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In spite of the presence of severe intraperitoneal lesions in fish receiving oil adjuvant 
no reduction in the weight was observed in these groups. However, vaccines including 
aluminium hydroxide yield less protection level, and seem to have bad influence in 
the weight of the cod. Also, this result is similar to the effect of Aluminium salts 
adjuvants in salmonids species (Horne et al., 1984; Midtlyng and Lillehaug, 1998b). 
In the present study, no side-effects were observed in fish received CpG with or 
without antigen. This finding is inconsistence with the previous report, which state 
that CpG has less toxic effect than other adjuvants (Weeratna et al., 2000).  
The absence of the intra- abdominal lesions and the high level of protection in fish 
vaccinated with the antigen alone, support that the use of oil-based vaccines should be 
discontinued as a vaccine component (Classen et al., 1992; Midtlyng, 1997).  There is 
a growing awareness that the vaccine side-effects has a negative effect on fish health 
and production. The reduction and elimination of side-effects with maintenance of 
long- term efficacy is never the less a decent goal, and it seems to be a possible goal 




















The aim of this study was to examine several adjuvants, alone or in combination, for 
their ability to enhance protective immunity against atypical furunculosis and to 
evaluate the degree of side-effects that they cause in Atlantic cod. 
The results obtained in cod demonstrated that intraperitoneal vaccination using 
adjuvanted bacterins is effective against atypical furunculosis in cod, and that the use 
of atypical A.salmonicida vaccine without adjuvant as well as FIA-containing 
vaccines protect Atlantic cod effectively. The presence of visible injection-site lesions 
was associated with vaccines containing FIA and Aluminium hydroxide alone. In 
contrast to previous studies in vibriosis, Atlantic cod produced specific antibodies 
against atypical A.salmonicida. The level of protection found correlated with the 
specific antibody responses in all the vaccinated groups where antigen was present.  
In addition, the following conclusions were derived from the result obtained in this 
study: 
q The intra-abdominal (i.p.) vaccination of Atlantic cod with the bacterin in saline 
gives a good protection without showing any symptoms of side-effects. This leads 
to conclude that it is effective to protect the Atlantic cod.  
q Antigen and CpG DNA adjuvant, with or without oil protect Atlantic cod against 
atypical furuculosis. CpG DNA used alone gave a very high mortality. Therefore, 
it is difficult to give the conclusive effect of the CpG as an adjuvant in cod.  
q The seriously side-effects of adjuvanted vaccines were found in Atlantic cod. 
Vaccination with FIA leads to adhesion between internal organs and the 
abdominal wall, inflammatory reaction due the presence of the rest of the vaccines 
in the form of spots. In addition, Aluminium hydroxide was found to suppress the 
growth and induced also inflammatory adhesion. These adjuvant systems should 
be avoided in the development of anti-atypical furunculosis vaccines and more 
effective alternative formulation is thus indispensable in cod. Further assessments 
of the side-effects after 6 months post vaccination are needed.  
q Specific antibody responses were demonstrated in all groups vaccinated with 
atypical A.salmonicida bacterin. The responses were strongest in groups receiving 
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Vaccines efficacy (RPS) in Atlantic cod (Gadus morhua L.) vaccinated with atypical 
A. salmonicida vaccines and challenged with atypical A. salmonicida aAs 4099, 12 








































































Appendix B:  
Antibody responses in Atlantic cod against atypical A.salmonicida measured in 
















































































Appendix C-1:  
χ2- test comparing the differences in mortality between the group 1-9 and the control 
group (saline). Degree of freedom of comparing two groups (df = 1).  
 
Comparisons χ2 P- value 
aAs+CpG+FIA (Gr1) Saline (Gr10) 33.5695 P < 0.001 
aAs+CpG (Gr2) Saline (Gr10) 33.5695 P < 0.001 
aAs+FIA (Gr3) Saline (Gr10) 37.5282 P < 0.001 
aAs+CpG+Alum    (Gr4) Saline (Gr10) 37.5282 P < 0.001 
aAs+saline   (Gr5) Saline (Gr10) 27.5686 P < 0.001 
CpG+FIA    (Gr6) Saline (Gr10) 26.0903 P < 0.001 
CpG     (Gr7) Saline (Gr10) 0.2431 n.s.* 
FIA      (Gr8) Saline (Gr10) 25.1537 P < 0.001 
CpG+Alum  (Gr9) Saline (Gr10) 0.6403 n.s.* 




 χ2 - test comparing differences in mortality between the groups received atypical 
A.salmonicida bacterin in combination either with CpG, FIA, CpG+ Alum 
(Alhydrogel) or CpG+FIA and the groups received the respective adjuvant alone. 
Degree of freedom of comparing two groups (df =1). 
 
 
Comparisons χ2 P- value 
aAs+CpG+FIA (Gr1)  CpG+FIA (Gr 6) 0.8035 n.s.* 
aAs+CpG  (Gr2) CpG  (Gr7) 40.1957 P < 0.001 
aAs+FIA   (Gr3)  FIA  (Gr8) 1.9619 n.s* 
aAs+CpG+Alum   (Gr4)  CpG+Alum (Gr9) 13.5064 P < 0.001 
aAs+saline (Gr5)  Saline (Gr10) 27.5686 P < 0.001 







Appendix C-3:  
χ2- test comparing differences in mortality between the group1-5 with each other. 
Degree of freedom of comparing two groups (df =1). 
 
 
Comparisons χ2 P- value 
aAs+CpG+FIA (Gr1) aAs+CpG   (Gr2) 0.8035 P < 0.1 
aAs+CpG+FIA (Gr1) aAs+FIA    (Gr3) 0.1188 P < 0.1 
aAs+CpG+FIA (Gr1)  aAs+CpG+Alum  (Gr4) 2.8998 P < 0.1 
aAs+CpG+FIA (Gr1) aAs + saline  (Gr5) 0.4953 P < 0.1 
aAs+CpG  (Gr2) aAs+FIA  (Gr3) 0.1188 P < 0.1 
aAs+CpG  (Gr2) aAs+CpG+Alum (Gr4) 2.8998 P < 0.1 
aAs+CpG  (Gr2) aAs + saline (Gr5) 0.4953 P < 0.1 
aAs+FIA  (Gr3) aAs+CpG+Alum (Gr4) 4.2103 P < 0.05* 
aAs+FIA  (Gr3) aAs + saline (Gr5) 1.1081 P < 0.1 
aAs+CpG+Alum (Gr4) aAs + saline (Gr5) 1.0358 P < 0.1 

















Appendix D:  
The mean weight of the fish at time of vaccination and 12 weeks post vaccination. 




Group No. Fish mean weight (g) before and after vaccination 
 At time of vaccination                              12 weeks post vaccination 
Gr 1       33.9± 9.3                                                             59 ± 16.5 
Gr 2      38.9 ± 10.7                                                           74.5 ± 24.5 
Gr 3      32.3 ± 6.5                                                            78.3 ± 26.7 
Gr 4      35.3 ± 8.8                                                            44.2 ± 13.6 
Gr 5      35.7 ±6.6                                                             73.9 ± 27.6 
Gr 6      35.3 ± 8.0                                                              66.3 ± 13.5 
Gr 7      35.3 ± 9.9                                                              79.8 ± 25.5 
Gr 8      31.4 ± 5.3                                                              65.0 ± 24.2 
Gr 9      31.8 ± 11.4                                                            59.9 ± 16.0 

















Appendix E:  
The fluorescent tagging system (Northwest marine technology, inc.) for the 10 groups 
of Atlantic cod vaccinated against atypical A. salmonicida used to tag the fish before 
the challenge experiment.  
 
 
Group Colour Direction Location 
1.  Green Left Operculum 
2.  Orange Left Operculum 
3.  Yellow Left Operculum 
4.  Red Left Operculum 
5.  Yellow/Yellow Left/Right Operculum 
6.  Green Right Operculum 
7.  Orange Right Operculum 
8.  Yellow Right Operculum 
9.  Red Right Operculum 















The temperature during the vaccination and challenge experiment. The challenge was 
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